Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q1 2026 · 10-Q
Revenue$3.20M$3.20M−11.4% vs Q1 2025 Net Income-$643.00K-$643.00KN/M vs Q1 2025 EPS Diluted$0.00$0.00— vs Q1 2025 Gross Profit$1,562,000−5.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flow$101,000N/M Free Cash Flowderived$98,000N/M Margins · derivedGross margin48.9%+2.9 pt vs Q1 2025
Operating margin-10.0%−10.3 pt vs Q1 2025
Net margin-20.1%−17.1 pt vs Q1 2025
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end